Analyst Research: Threshold Pharmaceuticals Inc (THLD.O)

THLD.O on Consolidated Issue listed on NASDAQ Capital Market

3.01USD
24 Oct 2014
Price Change (% chg)

$0.03 (+1.01%)
Prev Close
$2.98
Open
$2.99
Day's High
$3.01
Day's Low
$2.94
Volume
450,716
Avg. Vol
748,973
52-wk High
$5.93
52-wk Low
$2.82

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
THLD: Due Diligence Review: Forensic Earnings and Valuation 23 Oct 2014 New Constructs, LLC 9 25.00
Thomson Reuters Stock Report - THRESHOLD PHARMACEUTICALS, INC. (THLD-O) 22 Oct 2014 Thomson Reuters Stock Report 11 25.00
Threshold Pharmaceuticals 18 Oct 2014 S&P Capital IQ Quantitative Report 10 115.00
THRESHOLD PHARMACEUTICALS INC (THLD) 12-months forecast 17 Oct 2014 Pechala's Reports 1 15.00
THRESHOLD PHARMACEUTICALS INC (THLD) - REPORT FOR ACTIVE TRADERS 17 Oct 2014 Pechala's Reports 1 25.00
Threshold Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 17 Oct 2014 Reuters Investment Profile 12 20.00
Value Graph: THRESHOLD PHARMA -- THLD 16 Oct 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: THRESHOLD PHARMACEUTICALS (THLD) 11 Oct 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Harold Selick

59 Chief Executive Officer, Director

Robert Simon

79 2012 Senior Vice President - Regulatory Affairs and Quality Assurance

Joel Fernandes

44 2011 Vice President - Finance, Controller

Nipun Davar

46 2011 Vice President - Pharmaceutical Development and Manufacturing

Tillman Pearce

57 2012 Chief Medical Officer
Search Stocks